Shares of Synairgen plc (LON: SNG) climbed 9.8% on the first trading day of 2021 despite the biotech company not making any major announcements.
The biotech company’s last news was that it had expedited the design of the phase III trial of its SNG-001 COVID-19 treatment after talks with regulators to reduce the number of participants from 900 patients to 680 patients.
Synairgen’s drug has shown effectiveness against severe cases of the coronavirus and could be used widely to treat the virus following the recent wave of infections that have led to new lockdown measures in the UK and across Europe.
Ready to put what you’ve learned into practice?
Try IG’s platform with £10,000 in virtual funds and practise trading
without putting your own money at risk.
Try IG with a demo account →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Learn the markets with IG Academy
Build your knowledge with IG Academy educational content, then use a
demo account to practise what you’ve learned on the IG platform.
Explore IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
See how trading works before risking real money
IG’s demo gives you access to thousands of markets and £10,000 in
virtual funds, so you can explore the platform and test your ideas first.
Open an IG demo →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Turn trading theory into practical experience
Learn with IG Academy, explore charts and market tools, and practise
strategies in a simulated trading environment before going live.
Start practising with IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Ready to take your learning further?
IG combines market education, analysis and an established trading platform,
giving you the tools to keep learning as you develop your trading skills.
Discover IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Investors are waiting for the results of the phase III trial, which could lead to the drug being approved as an effective COVID-19 treatment and maybe even used on a global scale creating a major windfall for the company in future.
However, some analysts are concerned about the company’s over-dependence on its COVID-19 treatment as a future revenue generator, given that sales of the drug could drop substantially once the pandemic is under control.
Synairgen share price
Synairgen shares rallied 9.8% to trade at 168p having risen from its Thursday, December 31st closing price of 153p.
